A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Melanoma|Sarcoma|Gastrointestinal Stromal Tumor (GIST)|Head and Neck Cancer|Transitional Cell Carcinoma|Prostate Cancer|Ovarian Carcinoma|Esophageal Cancer|Breast Cancer
Interventions: BIOLOGICAL: Mixed bacterial vaccine
Sponsor: Ludwig Institute for Cancer Research
Collaborators: Krankenhaus Nordwest